PTAB Upholds 3 Teva Migraine Patents Challenged By Eli Lilly
The Patent Trial and Appeal Board upheld all claims in three Teva Pharmaceutical patents covering its migraine biologic Ajovy that were challenged by Eli Lilly, giving a boost to Teva's underlying...To view the full article, register now.
Already a subscriber? Click here to view full article